Participated · Equity · Mar 2026

Miraterra develops a soil intelligence platform that integrates geospatial tools, a proprietary soil DNA library, the Digitizer Raman‑spectroscopy device, and AI to translate biological and chemical soil data into actionable insights. The company acquired Trace Genomics’ assets in 2025, bringing additional IP, analytical tools and a laboratory in Ames, Iowa into its operations. Miraterra plans to expand measurement capabilities beyond soil to include plants and food and to scale global operations and partnerships across the agricultural value chain. The company says prior funding supported the launch of its Digitizer device and that its new C$16 million round will accelerate commercial rollout and deepen its AI and data science capabilities. Miraterra positions itself as a provider of high‑confidence, affordable measurement for farmers, food producers and policymakers to support productivity, nutrition and soil health.

Participated · Equity · Apr 2025

Growers Edge is a Johnston, IA-based company that provides financial products and data-driven tools for agricultural retailers, manufacturers, and lenders. The company offers a suite of products including its Crop Plan Warranty Program, land and climate intelligence solutions, digital mortgage lending products, and input lending tools. As a fintech platform it delivers data-backed products designed to reduce risk and promote agricultural innovation and growth. Growers Edge acquired AQUAOSO Technologies, expanding its farmland valuation tool to cover over 144 million acres, and has surpassed one million acres protected through its Crop Plan Warranty program. The company raised $25M and intends to use the funds to scale its financial solutions, expand its reach with more ag retailers and lenders, and drive adoption of climate-smart agricultural products and practices across the U.S. The business is led by CEO Matt Hansen. Growers Edge, founded in 2017, offers financial solutions to agtech vendors via an intelligence platform that designs warranty-backed crop management plans. The platform uses federal crop insurance actual production history (APH) data dating back 4–10 years to inform pricing and coverage. Retailers white‑label these warranty-backed plans, which typically cover 90–100% of a farmer’s APH yields. Its outcome-based warranty model issues refunds in cash or product if performance metrics are not met. The company leverages digital agriculture software to build predictive models that link product use to expected outcomes. Financially, Growers Edge recently closed a $5 million venture debt facility from Silicon Valley Bank and announced a $40 million Series B last summer. Management says the debt will enable faster growth with less equity dilution. Growers Edge Financial builds financial technology products and solutions designed to de-risk agtech adoption for farmers by offering tailored financial risk-management and data-backed prescriptions. The company leverages proprietary data and analytics to create product warranties and economic incentives that encourage technology adoption without selling seed, inputs, or equipment. Growers Edge positions its offerings to boost farm profitability and support long-term financial and environmental resiliency. The business plans to use fresh capital to grow its data science team and advance its AI platform. Management intends to expand market penetration across the U.S. and globally to accelerate adoption of sustainable ag innovations. The company emphasizes partnerships with ag retailers and technology and agent partners to scale distribution and impact.

Participated · Series A · Oct 2023

Pow.bio combines continuous-fermentation hardware with AI-controlled software called SOFe to accelerate process optimization and autonomous operation for synthetic-biology manufacturers. The company says its system enables a steady pace of inputs and outputs that is roughly 5x faster while requiring a fraction of traditional capital expenses. Pow.bio positions itself as a rapid-prototyping partner that can shorten development cycles to two or three months versus multi-month, costly iterations. It is already working with multiple clients, bringing in revenue and reporting at least 50% year-over-year growth in demand. The startup will deploy most of its new funding to build a demonstration facility in Alameda, California to move from gram-scale experimentation to production of hundreds of kilograms of finished products. The Alameda demo, slated to open summer 2024, is intended to serve 20–50 partners and be a blueprint for scaling to multiple locations. Pow.bio was founded in 2019 by Ouwei Wang and Shannon Hall. Pow.bio develops a process-based continuous fermentation platform that separates growth and production phases to keep microbes in an ultra-productive, non-growing state for extended runs. The company operates a 30-liter facility and is scaling to 300 liters while projecting roughly eightfold higher productivity at commercial scale using 50 cubic meter reactors for certain ingredients. Pow.bio positions itself as a ‘fermentation as a service’ provider, helping customers validate strains, optimize processes, and produce materials for regulatory and go-to-market testing. It reports it is already generating revenue and is working with about 30 clients but currently lacks capacity to meet inbound demand. The team holds contamination-control IP licensed from UC Berkeley and a growing patent family covering its process innovations and optimization technologies. Future plans include expanding capabilities, moving to a larger facility, pursuing joint ventures and licensing deals, and building larger manufacturing capacity with partners.

Participated · Series D · Jun 2023

Flywheel offers an enterprise imaging platform that aggregates, curates, and analyzes medical imaging and video data at scale, helping customers streamline research workflows and prepare AI-ready datasets. During 2025 the company broadened its product suite with a video viewing and annotation tool and launched Flywheel Validated, which supports 21 CFR Part 11–compliant imaging workflows for clinical trials. Its customer roster now includes 10 of the top 20 global pharmaceutical companies and 10 of the top 20 academic medical centers. Commercial traction was strong, with 43 % year-over-year growth in new business, a 40 % increase in committed revenue, and annual recurring revenue from pharma and device customers up 106 %. Net revenue retention exceeded 110 %, underscoring sticky usage and expansion within existing accounts. Backers of the company include Novalis LifeSciences, 8VC, NVIDIA, Microsoft, Novartis, and Intuitive Surgical. The new capital will be used to accelerate product innovation and further penetrate the clinical trial and AI model development markets.

Participated · Series A · May 2023

Pluton Biosciences isolates and develops novel microorganisms to create agricultural products that improve soil and capture carbon. Their lead product is a microbial cover crop designed to sequester carbon and nitrogen in soils. The company reports highly repeatable lab and greenhouse data and plans field testing this year to quantify sequestration and soil impacts. R&D continues on microbes that generate durable carbon for long-term soil persistence and on a discovered molecule that acts as an insecticide against fall armyworm. Pluton raised a $16.5M Series A to commercialize its most promising finds after a $6.6M seed round in 2021. The company has doubled headcount from 8 to 17, doubled office and lab space, and expects to double staff again over the next year. Pluton Biosciences has developed a platform it calls a "Micromining engine" to create and screen small populations of microbes that are otherwise unculturable, then isolate and sequence the organisms or genes responsible for desired phenotypes. The company says its approach lets it access and grow the roughly 99.999% of microbes not currently culturable. Early demonstrations include microbes that kill mosquitoes and microbe groupings predicted to sequester carbon in soil. Pluton is working with Bayer AG on a microbe-based soil additive the company predicts could remove nearly two tons of carbon per acre per year while replenishing soil nutrients. The team plans to commercialize the mosquito-derived natural pesticide and expand beyond initial sampling sources. Pluton raised a $6.6 million seed round to scale operations, move part-time staff to full-time and build out its lab.